Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enzastaurin and Bicalutamide in Prostate Cancer with Rising PSA
NCT00685633Phase 2Withdrawn
- Sponsor
- Eastern Cooperative Oncology Group
- Start
- Dec 2008
- Primary completion
- Jun 2010
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of enzastaurin in prostate cancer (PCa), sponsored by Eastern Cooperative Oncology Group. Planned start Dec 2008; status: withdrawn.
02
Drugs
enzastaurin
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00685633.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00685633.